C.M. Bidwell & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Sell |
12,767
-630
| -5% | -$15.3K | 0.16% | 89 |
|
|
2025
Q1 | $339K | Sell |
13,397
-223
| -2% | -$5.65K | 0.2% | 84 |
|
|
2024
Q4 | $361K | Buy |
13,620
+2,900
| +27% | +$76.9K | 0.22% | 76 |
|
|
2024
Q3 | $310K | Buy |
+10,720
| New | +$310K | 0.19% | 86 |
|
|
2022
Q3 | – | Sell |
-6,022
| Closed | -$316K | – | 524 |
|
|
2022
Q2 | $316K | Sell |
6,022
-2,415
| -29% | -$127K | 0.25% | 64 |
|
|
2022
Q1 | $437K | Sell |
8,437
-198
| -2% | -$10.3K | 0.29% | 56 |
|
|
2021
Q4 | $510K | Buy |
+8,635
| New | +$510K | 0.31% | 50 |
|
|
2019
Q3 | – | Sell |
-11,757
| Closed | -$483K | – | 470 |
|
|
2019
Q2 | $483K | Buy |
11,757
+10,940
| +1,339% | +$449K | 0.48% | 54 |
|
|
2019
Q1 | $33K | Hold |
817
| – | – | 0.03% | 279 |
|
|
2018
Q4 | $34K | Buy |
+817
| New | +$34K | 0.04% | 269 |
|
|
2017
Q1 | – | Sell |
-118
| Closed | -$4K | – | 280 |
|
|
2016
Q4 | $4K | Sell |
118
-130,615
| -100% | -$4.43M | ﹤0.01% | 225 |
|
|
2016
Q3 | $4.2M | Sell |
130,733
-395
| -0.3% | -$12.7K | 1% | 31 |
|
|
2016
Q2 | $4.38M | Sell |
131,128
-106
| -0.1% | -$3.54K | 1.09% | 21 |
|
|
2016
Q1 | $3.69M | Buy |
+131,234
| New | +$3.69M | 0.92% | 55 |
|
|
2014
Q2 | – | Sell |
-1,697
| Closed | -$52K | – | 280 |
|
|
2014
Q1 | $52K | Sell |
1,697
-79,946
| -98% | -$2.45M | 0.01% | 202 |
|
|
2013
Q4 | $2.37M | Sell |
81,643
-284
| -0.3% | -$8.26K | 0.59% | 83 |
|
|
2013
Q3 | $2.23M | Buy |
81,927
+295
| +0.4% | +$8.04K | 0.61% | 84 |
|
|
2013
Q2 | $2.17M | Buy |
+81,632
| New | +$2.17M | 0.64% | 80 |
|